Category Archives: Obesity Management

AANP Resources by Therapeutic AreaCE Courses The AANP CE Center offers a wide variety of free continuing education (CE) activities for members and nonmembers. The activities are updated frequently, and many obesity-related options are currently available. View Courses Developed by expert NPs to support education of patients with overweight and obesity, Lets Talk: Weight & Your Well-being, is a valuable engagement tool Continue reading →

This guideline covers preventing children, young people and adults becoming overweight or obese. Continue reading →

Click here for Hormonal Obesity Part I, and Part II In the current epidemic of obesity, there is a clear turning point in 1977. What was the reason? Perhaps the increased use of cars is the underlying cause of obesity. Continue reading →

May 08, 2019 (Heraldkeeper via COMTEX) -- Global Obesity Managements Market - Overview The global obesity managements market is growing with a swift phase; mainly due to increase in patient population and research and development done by market players to fill the gap of market. Continue reading →

Apr 29, 2019 (MARKITWIRED via COMTEX) -- VALLEY COTTAGE, N.Y. -High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes the expenditure significantly Continue reading →

CTAF, Washington State It is estimated that more than one-third of American adults and about 17% of adolescents are obese. The health effects of obesity are myriad and include the development of type 2 diabetes,hypertension, cardiovascular disease, cancer, high blood pressure, and sleep apnea. Obesity and itssequelae are estimated to generate $147 billion in health care costs in the US alone Continue reading →

Obesity is a complex and multi-factorial chronic disease with genetic, environmental, physiological and behavioural determinants that requires long-term care. In 2014-15, 63.4% of Australians aged 18 years and over were above normal weight, with 27.9% being obese [1]. Obesity is associated with a broad range of complications including type 2 diabetes, cardiovascular disease, dyslipidaemia, sleep apnoea, osteoarthritis, and certain types of cancers, which significantly impair quality of life. Continue reading →

Session 1:Obesity Obesityis a medical condition where the excess body fat accumulates in the body to an extent that it has a negative effect on health. It is defined by usingbody mass index (BMI) and is evaluated in terms of fat distribution and total cardiovascular risk factors. A person is considered as obese if the bodyweight is higher than 20%. Continue reading →

Insulin levels had always been assumed to go up or down with the blood glucose levels which led to the glycemic index which had always been assumed to be a surrogate measure of insulin levels. The glycemic index did not turn out to be as successful in weight control because glucose does not drive obesity Continue reading →

Sessions/Tracks Track 1: The Science of Obesity and Diabetes The prevalence of inordinate corpulence, quantified by body mass index has raised to unacceptable levels in both men and women in the Cumulated States and ecumenical with resultant hazardous health implicative insinuations. The global prevalence of obesity has nearly tripled since 1975. In 2016, more than 1.9 billion adults aged 18 were overweight Continue reading →